← back to search

Katharina Meier

Humboldt-Universität zu Berlin · DE
Area of research
Pathology and Forensic Medicine · Periodontics
Research interest
Research interests include Autoimmune Bullous Skin Diseases, Oral Health Pathology and Treatment, Psoriasis: Treatment and Pathogenesis, and Dermatology and Skin Diseases.
h-index
16
citations
1,137
works
95
NIH funding
primary concept
email

Recent publications

Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach
Acta Dermato Venereologica 2025cited by 6position: middledoi
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis
Journal for ImmunoTherapy of Cancer 2025cited by 3position: middledoi
Facets of shame and their impact on quality of life in patients with atopic dermatitis and psoriasis
Scientific Reports 2025cited by 3position: middledoi
Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
JDDG Journal der Deutschen Dermatologischen Gesellschaft 2024cited by 11position: middledoi
Interleukin‐21 in autoimmune and inflammatory skin diseases
European Journal of Immunology 2023cited by 42position: middledoi
The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus
Journal of the European Academy of Dermatology and Venereology 2023cited by 21position: lastdoi
Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS‐CoV‐2 in patients with pemphigus and bullous pemphigoid
Journal of the European Academy of Dermatology and Venereology 2023cited by 6position: middledoi
Diagnostik des okulären Schleimhautpemphigoids
Die Ophthalmologie 2023cited by 6position: middledoi
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
Annals of the Rheumatic Diseases 2022cited by 24position: middledoi
Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin
Frontiers in Immunology 2022cited by 16position: middledoi
Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2
Journal of the European Academy of Dermatology and Venereology 2021cited by 78position: lastdoi
Prevalence of <i>Candida species</i> in Psoriasis
Mycoses 2021cited by 18position: lastdoi
Immune serological diagnosis of pemphigus
Italian Journal of Dermatology and Venereology 2021cited by 12position: middledoi
Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody production
Journal of Allergy and Clinical Immunology 2020cited by 90position: middledoi
The inflammation in cutaneous lichen planus is dominated by IFN‐ϒ and IL‐21—A basis for therapeutic JAK1 inhibition
Experimental Dermatology 2020cited by 86position: middledoi
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
Frontiers in Immunology 2020cited by 27position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Kamran Ghoreschi · Clinical Research Center for Hair and Skin Science11 papers (2020–2024)Farzan Solimani · Humboldt-Universität zu Berlin9 papers (2020–2024)Franz J. Hilke · Humboldt-Universität zu Berlin4 papers (2021–2023)Julia Holstein · University of Tübingen4 papers (2020–2021)Alberto Mesas‐Fernández · Charité - Universitätsmedizin Berlin3 papers (2023–2023)Euna Bodner · Humboldt-Universität zu Berlin3 papers (2023–2024) · 2 papers (2025–2025)Alexander Nast · Humboldt-Universität zu Berlin2 papers (2023–2023) · 2 papers (2020–2021)Margitta Worm · Charité - Universitätsmedizin Berlin2 papers (2023–2023)Amrei Dilling · Humboldt-Universität zu Berlin2 papers (2021–2023)Alexander Thiem · University Hospital Schleswig-Holstein2 papers (2025–2025)Steffen Emmert · UConn Health2 papers (2025–2025)Iris Schäfer · University of Tübingen2 papers (2020–2020)Georgios Kokolakis · Psoriasis Association2 papers (2025–2025) · 2 papers (2025–2025)Caroline Mann · Johannes Gutenberg University Mainz2 papers (2025–2025)Franziska C. Ghoreschi · Charité - Universitätsmedizin Berlin2 papers (2020–2023) · 2 papers (2025–2025)Jens Waschke · Ludwig-Maximilians-Universität München2 papers (2020–2022)